Two Sigma Advisers’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-29,400
| Closed | -$13K | – | 2764 |
|
|
2022
Q3 | $13K | Sell |
29,400
-534,000
| -95% | -$236K | ﹤0.01% | 2471 |
|
|
2022
Q2 | $479K | Buy |
563,400
+308,600
| +121% | +$262K | ﹤0.01% | 1946 |
|
|
2022
Q1 | $1.4M | Buy |
254,800
+41,000
| +19% | +$226K | ﹤0.01% | 1452 |
|
|
2021
Q4 | $2.07M | Buy |
213,800
+70,500
| +49% | +$683K | 0.01% | 1184 |
|
|
2021
Q3 | $2.56M | Buy |
143,300
+111,100
| +345% | +$1.99M | 0.01% | 1117 |
|
|
2021
Q2 | $786K | Buy |
32,200
+20,200
| +168% | +$493K | ﹤0.01% | 1744 |
|
|
2021
Q1 | $318K | Sell |
12,000
-13,000
| -52% | -$345K | ﹤0.01% | 2198 |
|
|
2020
Q4 | $190K | Sell |
25,000
-1,200
| -5% | -$9.12K | ﹤0.01% | 2187 |
|
|
2020
Q3 | $131K | Sell |
26,200
-4,200
| -14% | -$21K | ﹤0.01% | 2241 |
|
|
2020
Q2 | $182K | Buy |
30,400
+2,500
| +9% | +$15K | ﹤0.01% | 2270 |
|
|
2020
Q1 | $124K | Buy |
+27,900
| New | +$124K | ﹤0.01% | 2273 |
|